Literature DB >> 19299505

Structure of granzyme C reveals an unusual mechanism of protease autoinhibition.

Dion Kaiserman1, Ashley M Buckle, Petra Van Damme, James A Irving, Ruby H P Law, Antony Y Matthews, Tanya Bashtannyk-Puhalovich, Chris Langendorf, Philip Thompson, Joël Vandekerckhove, Kris Gevaert, James C Whisstock, Phillip I Bird.   

Abstract

Proteases act in important homeostatic pathways and are tightly regulated. Here, we report an unusual structural mechanism of regulation observed by the 2.5-A X-ray crystal structure of the serine protease, granzyme C. Although the active-site triad residues adopt canonical conformations, the oxyanion hole is improperly formed, and access to the primary specificity (S1) pocket is blocked through a reversible rearrangement involving Phe-191. Specifically, a register shift in the 190-strand preceding the active-site serine leads to Phe-191 filling the S1 pocket. Mutation of a unique Glu-Glu motif at positions 192-193 unlocks the enzyme, which displays chymase activity, and proteomic analysis confirms that activity of the wild-type protease can be released through interactions with an appropriate substrate. The 2.5-A structure of the unlocked enzyme reveals unprecedented flexibility in the 190-strand preceding the active-site serine that results in Phe-191 vacating the S1 pocket. Overall, these observations describe a broadly applicable mechanism of protease regulation that cannot be predicted by template-based modeling or bioinformatic approaches alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299505      PMCID: PMC2666993          DOI: 10.1073/pnas.0811968106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Assessment of phase accuracy by cross validation: the free R value. Methods and applications.

Authors:  A T Brünger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-01-01

2.  cDNA cloning of granzyme C, a granule-associated serine protease of cytolytic T lymphocytes.

Authors:  D Jenne; C Rey; D Masson; K K Stanley; J Herz; G Plaetinck; J Tschopp
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

3.  Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.

Authors:  Kris Gevaert; Marc Goethals; Lennart Martens; Jozef Van Damme; An Staes; Grégoire R Thomas; Joël Vandekerckhove
Journal:  Nat Biotechnol       Date:  2003-03-31       Impact factor: 54.908

4.  Three-dimensional structure of the rSly1 N-terminal domain reveals a conformational change induced by binding to syntaxin 5.

Authors:  Demet Araç; Irina Dulubova; Jimin Pei; Iryna Huryeva; Nick V Grishin; Josep Rizo
Journal:  J Mol Biol       Date:  2004-12-24       Impact factor: 5.469

5.  Cell death induced by granzyme C.

Authors:  Hillary Johnson; Luca Scorrano; Stanley J Korsmeyer; Timothy J Ley
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

Review 6.  Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation.

Authors:  D E Jenne; J Tschopp
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

7.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.

Authors:  Felipe Andrade; Edward Fellows; Dieter E Jenne; Antony Rosen; C S H Young
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

8.  In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity.

Authors:  Simon J McRae; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  Biochemistry       Date:  2007-03-08       Impact factor: 3.162

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  Crystal structure of wild-type human thrombin in the Na+-free state.

Authors:  Daniel J D Johnson; Ty E Adams; Wei Li; James A Huntington
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

View more
  6 in total

1.  Selecting protein N-terminal peptides by combined fractional diagonal chromatography.

Authors:  An Staes; Francis Impens; Petra Van Damme; Bart Ruttens; Marc Goethals; Hans Demol; Evy Timmerman; Joël Vandekerckhove; Kris Gevaert
Journal:  Nat Protoc       Date:  2011-07-14       Impact factor: 13.491

2.  CD8αα+MHC Class II+ Cell with the Capacity To Terminate Autoimmune Inflammation Is a Novel Antigen-Presenting NK-like Cell in Rats.

Authors:  Jean Wu; Colin Carlock; April Ross; Junbo Shim; Yahuan Lou
Journal:  J Immunol       Date:  2016-10-31       Impact factor: 5.422

3.  Conservation of the extended substrate specificity profiles among homologous granzymes across species.

Authors:  Kim Plasman; Sebastian Maurer-Stroh; Jamshaid Ahmad; Han Hao; Dion Kaiserman; Fernanda L Sirota; Veronique Jonckheere; Phillip I Bird; Kris Gevaert; Petra Van Damme
Journal:  Mol Cell Proteomics       Date:  2013-06-20       Impact factor: 5.911

4.  The iceLogo web server and SOAP service for determining protein consensus sequences.

Authors:  Davy Maddelein; Niklaas Colaert; Iain Buchanan; Niels Hulstaert; Kris Gevaert; Lennart Martens
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

5.  Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics.

Authors:  Blake T Riley; Olga Ilyichova; Mauricio G S Costa; Benjamin T Porebski; Simon J de Veer; Joakim E Swedberg; Itamar Kass; Jonathan M Harris; David E Hoke; Ashley M Buckle
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

6.  The Online Protein Processing Resource (TOPPR): a database and analysis platform for protein processing events.

Authors:  Niklaas Colaert; Davy Maddelein; Francis Impens; Petra Van Damme; Kim Plasman; Kenny Helsens; Niels Hulstaert; Joël Vandekerckhove; Kris Gevaert; Lennart Martens
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.